Short Interest in Fagron NV (OTCMKTS:ARSUF) Declines By 31.8%

Fagron NV (OTCMKTS:ARSUF) was the recipient of a significant decrease in short interest during the month of December. As of December 15th, there was short interest totaling 6,334 shares, a decrease of 31.8% from the November 30th total of 9,294 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is currently ? days. Based on an average trading volume of 0 shares, the days-to-cover ratio is currently ? days.

Fagron Price Performance

ARSUF opened at $23.50 on Wednesday. The company has a fifty day moving average of $23.50 and a 200 day moving average of $24.30. Fagron has a fifty-two week low of $23.50 and a fifty-two week high of $23.66.

About Fagron

Fagron (OTCMKTS:ARSUF) is a global pharmaceutical compounding company that supplies raw materials, equipment and services to compounding pharmacies, hospitals and healthcare practitioners. Its portfolio encompasses a range of pharmaceutical ingredients, dosage forms and specialized compounding solutions designed to meet patient-specific needs. The company supports the preparation of customized medications in areas such as dermatology, pain management, hormone replacement therapy and veterinary medicine, providing both sterile and non-sterile compounding products.

Headquartered in Rotterdam, the Netherlands, Fagron operates in more than 55 countries across Europe, the Americas, Asia-Pacific and the Middle East & Africa.